Aprea Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Aprea Therapeutics

09/11/2021 24:04

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly adjusted
loss of 45 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 45 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Aprea Therapeutics Inc's reported EPS for the quarter was a
loss of 45 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Aprea Therapeutics Inc shares had fallen by 1.4% this
quarter and gained 2.4% so far this year.
* The company reported a quarterly loss of $9.45 million.
* Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $4.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell." 
This summary was machine generated November 9 at 12:04 a.m.
 ​All figures in US dollars unless otherwise stated